Corrigendum to “BRG1 alleviates microglial activation by promoting the KEAP1-NRF2/HO-1 signaling pathway and minimizing oxidative damage in cerebral ischemia–reperfusion” [Int. Immunopharmacol. 119 (2023) 110201]

Corrigendum to “BRG1 alleviates microglial activation by promoting the KEAP1-NRF2/HO-1 signaling pathway and minimizing oxidative damage in cerebral ischemia–reperfusion” [Int. Immunopharmacol. 119 (2023) 110201]

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International immunopharmacology 2024-03, Vol.129, p.111541-111541, Article 111541
Hauptverfasser: Guo, Kongwei, Shang, Yanxing, Wang, Zhao, Li, Yu, Chen, Jinliang, Zhu, Baofeng, Zhang, Dongmei, Chen, Jianrong
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 111541
container_issue
container_start_page 111541
container_title International immunopharmacology
container_volume 129
creator Guo, Kongwei
Shang, Yanxing
Wang, Zhao
Li, Yu
Chen, Jinliang
Zhu, Baofeng
Zhang, Dongmei
Chen, Jianrong
description
doi_str_mv 10.1016/j.intimp.2024.111541
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2929130865</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1567576924000596</els_id><sourcerecordid>2929130865</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2021-b794b09b3a5b1d817fc0b33cd6bf84e0f58b4571bbdb7731f98e3169c6d47e9a3</originalsourceid><addsrcrecordid>eNp9UctuFDEQHCEQCYE_QMjHcJiJe95zQQqrPFZEBEVwQmjkR8-uV2PPxPYsLKf9B67wYxz3S_BqA0dO3WpXV7mrougl0AQolGerRBmv9JikNM0TAChyeBQdQ13VMVS0eBz6oqzioiqbo-iZcytKwzyHp9FRVmc0zfLiOPo9G6xVCzRy0sQPZLf9-fbuCgjre1wr5tERrYQdFr1iPWHCqzXzajCEb8hoBz14ZRbEL5G8uzj_APH7u8v07Po2BuLUwrB-_zoyv_zKNoQZGciM0ur7fjx8UzJwrZFIptkCiTJEoEVug5JyYolasd32h8URbTe5oLrb_iKf58YnZK71ZIZxyaxmYugTAtCQ02BF9jq0NKXw5Xn0pGO9wxcP9ST6dHnxcXYd39xezWfnN7EIcIh51eScNjxjBQdZQ9UJyrNMyJJ3dY60K2qeFxVwLnlVZdA1NWZQNqKUeYUNy06i0wNv8ON-QudbHX6Pfc8MDpNr0yZtIKN1WQRofoAGR52z2LWjVZrZTQu03afartpDqu0-1faQalh79aAwcY3y39LfGAPgzQGA4c61Qts6odAIlMqi8K0c1P8V_gCfqLjg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2929130865</pqid></control><display><type>article</type><title>Corrigendum to “BRG1 alleviates microglial activation by promoting the KEAP1-NRF2/HO-1 signaling pathway and minimizing oxidative damage in cerebral ischemia–reperfusion” [Int. Immunopharmacol. 119 (2023) 110201]</title><source>ScienceDirect Journals (5 years ago - present)</source><creator>Guo, Kongwei ; Shang, Yanxing ; Wang, Zhao ; Li, Yu ; Chen, Jinliang ; Zhu, Baofeng ; Zhang, Dongmei ; Chen, Jianrong</creator><creatorcontrib>Guo, Kongwei ; Shang, Yanxing ; Wang, Zhao ; Li, Yu ; Chen, Jinliang ; Zhu, Baofeng ; Zhang, Dongmei ; Chen, Jianrong</creatorcontrib><identifier>ISSN: 1567-5769</identifier><identifier>EISSN: 1878-1705</identifier><identifier>DOI: 10.1016/j.intimp.2024.111541</identifier><identifier>PMID: 38302345</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><ispartof>International immunopharmacology, 2024-03, Vol.129, p.111541-111541, Article 111541</ispartof><rights>2024 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.intimp.2024.111541$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38302345$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Guo, Kongwei</creatorcontrib><creatorcontrib>Shang, Yanxing</creatorcontrib><creatorcontrib>Wang, Zhao</creatorcontrib><creatorcontrib>Li, Yu</creatorcontrib><creatorcontrib>Chen, Jinliang</creatorcontrib><creatorcontrib>Zhu, Baofeng</creatorcontrib><creatorcontrib>Zhang, Dongmei</creatorcontrib><creatorcontrib>Chen, Jianrong</creatorcontrib><title>Corrigendum to “BRG1 alleviates microglial activation by promoting the KEAP1-NRF2/HO-1 signaling pathway and minimizing oxidative damage in cerebral ischemia–reperfusion” [Int. Immunopharmacol. 119 (2023) 110201]</title><title>International immunopharmacology</title><addtitle>Int Immunopharmacol</addtitle><issn>1567-5769</issn><issn>1878-1705</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9UctuFDEQHCEQCYE_QMjHcJiJe95zQQqrPFZEBEVwQmjkR8-uV2PPxPYsLKf9B67wYxz3S_BqA0dO3WpXV7mrougl0AQolGerRBmv9JikNM0TAChyeBQdQ13VMVS0eBz6oqzioiqbo-iZcytKwzyHp9FRVmc0zfLiOPo9G6xVCzRy0sQPZLf9-fbuCgjre1wr5tERrYQdFr1iPWHCqzXzajCEb8hoBz14ZRbEL5G8uzj_APH7u8v07Po2BuLUwrB-_zoyv_zKNoQZGciM0ur7fjx8UzJwrZFIptkCiTJEoEVug5JyYolasd32h8URbTe5oLrb_iKf58YnZK71ZIZxyaxmYugTAtCQ02BF9jq0NKXw5Xn0pGO9wxcP9ST6dHnxcXYd39xezWfnN7EIcIh51eScNjxjBQdZQ9UJyrNMyJJ3dY60K2qeFxVwLnlVZdA1NWZQNqKUeYUNy06i0wNv8ON-QudbHX6Pfc8MDpNr0yZtIKN1WQRofoAGR52z2LWjVZrZTQu03afartpDqu0-1faQalh79aAwcY3y39LfGAPgzQGA4c61Qts6odAIlMqi8K0c1P8V_gCfqLjg</recordid><startdate>20240310</startdate><enddate>20240310</enddate><creator>Guo, Kongwei</creator><creator>Shang, Yanxing</creator><creator>Wang, Zhao</creator><creator>Li, Yu</creator><creator>Chen, Jinliang</creator><creator>Zhu, Baofeng</creator><creator>Zhang, Dongmei</creator><creator>Chen, Jianrong</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20240310</creationdate><title>Corrigendum to “BRG1 alleviates microglial activation by promoting the KEAP1-NRF2/HO-1 signaling pathway and minimizing oxidative damage in cerebral ischemia–reperfusion” [Int. Immunopharmacol. 119 (2023) 110201]</title><author>Guo, Kongwei ; Shang, Yanxing ; Wang, Zhao ; Li, Yu ; Chen, Jinliang ; Zhu, Baofeng ; Zhang, Dongmei ; Chen, Jianrong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2021-b794b09b3a5b1d817fc0b33cd6bf84e0f58b4571bbdb7731f98e3169c6d47e9a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Guo, Kongwei</creatorcontrib><creatorcontrib>Shang, Yanxing</creatorcontrib><creatorcontrib>Wang, Zhao</creatorcontrib><creatorcontrib>Li, Yu</creatorcontrib><creatorcontrib>Chen, Jinliang</creatorcontrib><creatorcontrib>Zhu, Baofeng</creatorcontrib><creatorcontrib>Zhang, Dongmei</creatorcontrib><creatorcontrib>Chen, Jianrong</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International immunopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Guo, Kongwei</au><au>Shang, Yanxing</au><au>Wang, Zhao</au><au>Li, Yu</au><au>Chen, Jinliang</au><au>Zhu, Baofeng</au><au>Zhang, Dongmei</au><au>Chen, Jianrong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Corrigendum to “BRG1 alleviates microglial activation by promoting the KEAP1-NRF2/HO-1 signaling pathway and minimizing oxidative damage in cerebral ischemia–reperfusion” [Int. Immunopharmacol. 119 (2023) 110201]</atitle><jtitle>International immunopharmacology</jtitle><addtitle>Int Immunopharmacol</addtitle><date>2024-03-10</date><risdate>2024</risdate><volume>129</volume><spage>111541</spage><epage>111541</epage><pages>111541-111541</pages><artnum>111541</artnum><issn>1567-5769</issn><eissn>1878-1705</eissn><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>38302345</pmid><doi>10.1016/j.intimp.2024.111541</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1567-5769
ispartof International immunopharmacology, 2024-03, Vol.129, p.111541-111541, Article 111541
issn 1567-5769
1878-1705
language eng
recordid cdi_proquest_miscellaneous_2929130865
source ScienceDirect Journals (5 years ago - present)
title Corrigendum to “BRG1 alleviates microglial activation by promoting the KEAP1-NRF2/HO-1 signaling pathway and minimizing oxidative damage in cerebral ischemia–reperfusion” [Int. Immunopharmacol. 119 (2023) 110201]
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T08%3A25%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Corrigendum%20to%20%E2%80%9CBRG1%20alleviates%20microglial%20activation%20by%20promoting%20the%20KEAP1-NRF2/HO-1%20signaling%20pathway%20and%20minimizing%20oxidative%20damage%20in%20cerebral%20ischemia%E2%80%93reperfusion%E2%80%9D%20%5BInt.%20Immunopharmacol.%20119%20(2023)%20110201%5D&rft.jtitle=International%20immunopharmacology&rft.au=Guo,%20Kongwei&rft.date=2024-03-10&rft.volume=129&rft.spage=111541&rft.epage=111541&rft.pages=111541-111541&rft.artnum=111541&rft.issn=1567-5769&rft.eissn=1878-1705&rft_id=info:doi/10.1016/j.intimp.2024.111541&rft_dat=%3Cproquest_cross%3E2929130865%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2929130865&rft_id=info:pmid/38302345&rft_els_id=S1567576924000596&rfr_iscdi=true